How to Start a TRT and Hormone Therapy Business

If you want to start a TRT business, build it as a clinician-led, state-aware healthcare operation first and a brand second. The core requirements are controlled-substance compliance, a lab workflow that is either CLIA-ready or clearly limited to specimen collection and outside testing, recurring billing that follows FTC rules, and a licensing model that fits every state you plan to serve.

That means the real launch sequence is not logo, landing page, and ads. It is governance, licensure, clinical oversight, lab design, billing terms, and documentation. Once those pieces are mapped, you can evaluate whether your model belongs in a virtual care setup, a hybrid clinic, or a referral-based structure supported by infrastructure such as MDLaunchr and WhiteLabelClinic.com.

Start with the business model, not the funnel

A testosterone clinic business model can look simple from the outside, but the operating model matters more than the offer. Before you build pricing or marketing, decide which of these structures you are actually launching:

• Direct-to-consumer telehealth practice with clinician review and controlled-substance prescribing where allowed.
• Hybrid clinic with telehealth plus in-person services, labs, or follow-up.
• Membership-based hormone optimization business startup with recurring care access and periodic clinical review.
• Referral or coordination model that supports patient intake, scheduling, and operations but leaves clinical decisions to licensed professionals.

If you are still clarifying how clinical oversight, licensure, and operations should be separated, our guide on whether a telehealth business needs a medical director is a useful companion piece.

The compliance stack you need from day one

A launch-ready TRT or hormone therapy practice usually needs four layers working together:

Testosterone is listed by the DEA as a Schedule III controlled substance, so a TRT business should plan for controlled-substance workflows rather than ordinary retail-medication operations. At the federal level, telemedicine flexibilities currently allow certain controlled-substance prescribing through December 31, 2026, but the prescription still has to be for a legitimate medical purpose and comply with federal and state law.

Lab workflow: choose your testing model before launch

One of the biggest mistakes founders make is treating labs as an afterthought. In reality, your lab design determines operational cost, compliance burden, and vendor relationships.

There are two basic paths:

1) Order outside labs only

In this model, your practice sends patients to an outside laboratory and uses those results for clinician review. The practice does not perform the testing itself.

2) Collect specimens or perform testing on site

If your business performs actual testing on human-derived material for diagnosis, prevention, treatment, or health assessment, CMS says CLIA applies. CMS also notes that specimen collection alone does not make a site a laboratory, but actual testing generally changes the compliance picture.

That distinction matters because a clinic that simply draws blood is not the same as a clinic that runs assays in-house. If you are building a model around specimen handling, test ordering, and follow-up workflows, the broader lab and operations questions are similar to the ones discussed in how telehealth licensing affects business setup.

Quick lab decision check

Use this sequence before you sign any lab vendor contract:

• Are you only ordering tests from another lab?
• Will your site collect specimens?
• Will you perform any actual testing on-site?
• If yes, what CLIA category will apply?
• Does your target state have separate lab licensing rules in addition to CLIA?

CMS says some states have their own laboratory licensing laws, so a national launch cannot rely on CLIA alone. That is one of the reasons multi-state operators need state-by-state review before they promise a uniform patient experience.

State licensure is not optional just because the visit is virtual

HHS telehealth guidance says providers should review state licensure laws and stay current on telehealth prescribing rules. For a national TRT or hormone therapy business, that means your service area should be defined by where each clinician is authorized to practice, not where your website is visible.

Three state-level issues usually require separate review:

• Telehealth practice authority: Can the clinician treat patients located in that state?
• Controlled-substance registration or prescribing rules: Does the state add requirements beyond federal law?
• Corporate practice and ownership restrictions: Can a non-clinician own or control the clinical entity, and how must fees or supervision be structured?

Those issues are not the same everywhere, and they are not solved by a generic national template. If you are considering a broader telehealth build, our article on how to start a telehealth business helps frame the operational side without turning the launch into a one-size-fits-all checklist.

Recurring billing needs a real cancellation workflow

A lot of hormone therapy clinic launch plans assume memberships are mostly a marketing decision. In practice, membership design is a compliance decision too.

The FTC’s negative-option rule covers recurring billing models, including business-to-business negative-option programs. For a TRT business, that means your subscription terms should be clear before the first charge, your customer consent should be explicit, and cancellation should be simple and effective.

At minimum, your billing design should answer these questions:

• What is the recurring charge for?
• When does billing begin?
• What happens after a trial, introductory period, or auto-renewal?
• How does the customer cancel?
• Does cancellation immediately stop future charges?
• Are the material terms disclosed clearly before billing?

If your model includes membership billing, this is also where the difference between a good offer and a compliant offer becomes visible. A clean recurring-revenue system is part of the infrastructure, not just the checkout page.

Marketing must stay inside the evidence you can verify

Hormone optimization businesses often run into trouble when the marketing promises outpace the clinical record or the supply chain. FDA guidance on compounded drugs warns that online or telehealth purchasers may not know the identity or regulatory status of the compounder, and drug promotion must be truthful, non-misleading, and accurate.

That does not mean you cannot market a TRT or hormone therapy practice. It does mean your claims should stay grounded in what your clinicians, lab partners, and pharmacy relationships can actually support.

Use conservative language such as:

• clinician-led evaluation
• individualized care planning
• structured follow-up
• regulated prescribing workflow
• coordinated lab and pharmacy relationships

Avoid claims that imply guaranteed outcomes, universal access, or regulatory approval where none exists.

A founder-friendly launch framework

When you are evaluating how to start a TRT business, run the opportunity through this five-part framework:

1) Clinical authority

Do you have licensed clinicians who can make independent medical decisions, document care, and prescribe within scope?

2) Regulatory fit

Does your model account for DEA controlled-substance rules, state licensure, state lab requirements, and any ownership restrictions?

3) Lab path

Are you ordering outside tests, collecting specimens, or performing testing?

4) Revenue design

Are you using one-time consults, memberships, subscriptions, or a hybrid? If recurring billing is involved, is the cancellation flow compliant?

5) Operating infrastructure

Do you have scheduling, intake, charting, consent, and coordination tools that can support the clinical workflow without blurring the line between business operations and medical decision-making?

That last point is where a platform can help, but it should not pretend to replace licensure, prescribing authority, or legal review. MDLaunchr and WhiteLabelClinic.com are positioned as infrastructure support for qualified businesses that need to coordinate the operational and compliance layers of launch.

What to verify before you go live

Use this pre-launch checklist before opening enrollment:

• Confirm which states you will serve.
• Verify each clinician’s licensure and telehealth authority.
• Confirm whether testosterone or other controlled medications will be part of the workflow.
• Decide whether you are only ordering labs or also performing testing.
• Review CLIA and state laboratory requirements if on-site testing is involved.
• Review recurring billing disclosures and cancellation mechanics.
• Make sure marketing claims match the care model and supply chain.
• Document who makes clinical decisions and who handles operations.

If you are early in the process and want to see the kinds of programs that can be supported by a compliance-first infrastructure model, see the programs you can launch.

FAQs

Is testosterone treated like a controlled substance in federal materials?

Yes. DEA materials list testosterone as Schedule III, so a TRT practice should build controlled-substance compliance into the business model from the start.

Can a TRT clinic prescribe through telehealth?

Federal telehealth flexibilities currently allow certain controlled-substance prescribing through December 31, 2026, subject to conditions. That does not remove state law, licensure, or legitimate-medical-purpose requirements.

Do I need CLIA if I open a hormone clinic?

Not necessarily. If you only collect specimens or order outside labs, that is different from performing testing. If you perform actual testing on human-derived material, CLIA planning is needed.

Can I run a membership model for hormone therapy?

Yes, but recurring billing must be structured to meet FTC negative-option requirements, including clear disclosure, informed consent, and a simple cancellation process.

Can I launch nationally with one set of rules?

No. HHS and CMS both point operators back to state law for licensure and lab requirements. A national brand still has to operate through state-specific clinical authority and compliance.

Bottom line

A hormone therapy or TRT business is not just a marketing concept with appointments attached. It is a regulated clinical-service model that depends on licensure, prescribing authority, lab design, billing compliance, and truthful promotion.

If you want a business that can scale without blurring clinical and operational responsibilities, start by building the infrastructure around the rules first and the offer second.